The SNX25–Nrf2 axis in dMacs has the potential to bridge the painless phenotype of HSAN V to hyperalgesic conditions and could represent a promising alternative to anti-NGF monoclonal antibodies. The gene discussed is NGF; the disease is hereditary sensory and autonomic neuropathy.